BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 3292395)

  • 1. Molecular mechanisms of CTL-mediated lysis: a cellular perspective.
    Clark W; Ostergaard H; Gorman K; Torbett B
    Immunol Rev; 1988 Mar; 103():37-51. PubMed ID: 3292395
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of cytoplasmic granules in cytotoxicity by large granular lymphocytes and cytotoxic T lymphocytes.
    Henkart P; Henkart M; Millard P; Frederikse P; Bluestone J; Blumenthal R; Yue C; Reynolds C
    Adv Exp Med Biol; 1985; 184():121-38. PubMed ID: 3875972
    [No Abstract]   [Full Text] [Related]  

  • 3. Exocytosis of cytolytic granules may not be required for target cell lysis by cytotoxic T-lymphocytes.
    Trenn G; Takayama H; Sitkovsky MV
    Nature; 1987 Nov 5-11; 330(6143):72-4. PubMed ID: 3118213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cloned cytotoxic T lymphocytes as target cells. II. Polarity of lysis revisited.
    Gorman K; Liu CC; Blakely A; Young JD; Torbett BE; Clark WR
    J Immunol; 1988 Oct; 141(7):2211-5. PubMed ID: 3262651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of cytoplasmic granules in lymphocyte cytotoxicity.
    Henkart P; Yue CC
    Prog Allergy; 1988; 40():82-110. PubMed ID: 3281172
    [No Abstract]   [Full Text] [Related]  

  • 6. Resistance of primary CD8+ cytotoxic T lymphocytes to lysis by cytotoxic granules from cloned T cell lines.
    Nagler-Anderson C; Verret CR; Firmenich AA; Berne M; Eisen HN
    J Immunol; 1988 Nov; 141(10):3299-305. PubMed ID: 2972770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An anergic cytotoxic T lymphocyte clone exhibits granule exocytosis-mediated cytotoxicity.
    Kuwano K; Akashi A; Arai S
    Cell Immunol; 1998 May; 185(2):114-22. PubMed ID: 9636689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Highly lytic in vivo primed cytolytic T lymphocytes devoid of lytic granules and BLT-esterase activity acquire these constituents in the presence of T cell growth factors upon blast transformation in vitro.
    Berke G; Rosen D
    J Immunol; 1988 Sep; 141(5):1429-36. PubMed ID: 3261748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Degranulating cytotoxic lymphocytes inflict multiple damage pathways on target cells.
    Henkart PA; Williams MS; Nakajima H
    Curr Top Microbiol Immunol; 1995; 198():75-93. PubMed ID: 7774284
    [No Abstract]   [Full Text] [Related]  

  • 10. Mechanism of target cell lysis by cytotoxic T lymphocytes (CTL) employing RSV-induced H-2 congenic and recombinant mouse tumor cells: demonstration of soluble mediators released from H-2-restricted CTL clones.
    Haraguchi S; Fujii T; Matsuo T; Yoshida TO
    Cell Immunol; 1988 Apr; 112(2):279-92. PubMed ID: 2833355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanistic, functional and immunopharmacological implications of biochemical studies of antigen receptor-triggered cytolytic T-lymphocyte activation.
    Sitkovsky MV
    Immunol Rev; 1988 Mar; 103():127-60. PubMed ID: 3134292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of cytotoxicity by natural killer (NK) cells.
    Herberman RB; Reynolds CW; Ortaldo JR
    Annu Rev Immunol; 1986; 4():651-80. PubMed ID: 3518752
    [No Abstract]   [Full Text] [Related]  

  • 13. A comparison of the cytolytic properties of murine primary CD8+ cytotoxic T lymphocytes and cloned cytotoxic T cell lines.
    Nagler-Anderson C; Allbritton NL; Verret CR; Eisen HN
    Immunol Rev; 1988 Mar; 103():111-25. PubMed ID: 3134291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium ion concentrations and DNA fragmentation in target cell destruction by murine cloned cytotoxic T lymphocytes.
    Allbritton NL; Verret CR; Wolley RC; Eisen HN
    J Exp Med; 1988 Feb; 167(2):514-27. PubMed ID: 2450162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of DNA degradation in target cells lysed by granules derived from cytolytic T lymphocytes.
    Gromkowski SH; Brown TC; Masson D; Tschopp J
    J Immunol; 1988 Aug; 141(3):774-8. PubMed ID: 3260910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxic lymphokines produced by cloned human cytotoxic T lymphocytes. II. A novel CTL-produced cytotoxin that is antigenically distinct from tumor necrosis factor and alpha-lymphotoxin.
    Green LM; Reade JL; Ware CF; Devlin PE; Liang CM; Devlin JJ
    J Immunol; 1986 Dec; 137(11):3488-93. PubMed ID: 2431035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Localization of Fas ligand in cytoplasmic granules of CD8+ cytotoxic T lymphocytes and natural killer cells: participation of Fas ligand in granule exocytosis model of cytotoxicity.
    Kojima Y; Kawasaki-Koyanagi A; Sueyoshi N; Kanai A; Yagita H; Okumura K
    Biochem Biophys Res Commun; 2002 Aug; 296(2):328-36. PubMed ID: 12163021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ECH, an epoxycyclohexenone derivative that specifically inhibits Fas ligand-dependent apoptosis in CTL-mediated cytotoxicity.
    Mitsui T; Miyake Y; Kakeya H; Osada H; Kataoka T
    J Immunol; 2004 Mar; 172(6):3428-36. PubMed ID: 15004142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular mechanisms of lymphocyte-mediated lysis of tumor cells.
    Arancia G; Malorni W; Donelli G
    Ann Ist Super Sanita; 1990; 26(3-4):369-84. PubMed ID: 2151107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance and susceptibility of neural cells to lysis by cytotoxic lymphocytes and by cytolytic granules.
    Keane RW; Tallent MW; Podack ER
    Transplantation; 1992 Sep; 54(3):520-6. PubMed ID: 1412733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.